About Rivastigmine Hydrogen Tartrate API
Therapeutic CategoryCentral Nervous System (CNS)

CAS Number
129101-54-8
API Technology
Synthetic
Dose Form
Film (Transdermal), Oral Solid/Capsules
Dr Reddy's Development Status
Available
Available Regulatory Filing
USDMF, CEP Submitted, EUDMF, China DMF
Mechanism of Action
Rivastigmine is a type of medicine called an acetylcholinesterase inhibitor. It works by slowing the breakdown of a neurotransmitter in the brain called acetylcholine.
Indication
EXELON is an acetylcholinesterase inhibitor indicated for treatment of:
- Mild to moderate dementia of the Alzheimer’s type
- Mild to moderate dementia associated with Parkinson’s disease
Related APIs
Request for Quotation
Get in touch with us by filling out the form below. Our team will reach out to you shortly!
Disclaimer
No information on this website, including any reference to any product or service constitutes an offer for sale or be construed as representing an offer for sale. Products protected under valid patents are not offered or supplied for commercial use. However, in certain cases, at Dr. Reddy's sole discretion, and subject to local legal requirement, the research quantities of such products may be offered for the purpose of regulatory submissions under Section 107A of the Indian Patent Act (Bolar exemption), wherever such regulatory exemptions exist. The buyers should make their independent evaluation of the product or service including, patent scenario in their respective markets and will be responsible for all patent related liabilities Dr. Reddy's disclaims all warranties, express or implied, including but not limited to warranties of merchantability, fitness for a particular purpose and non-infringement.